Lantheus Holdings Inc

LNTH · Moat type: REGULIERUNG

MoatScore

8/10

Fair Value

143 USD

Margin of Safety

+26.2 %

Rating

STARK

Lantheus Holdings develops, produces, and markets diagnostic imaging agents – in particular radioactive tracers and contrast agents for nuclear medicine – which are primarily used in oncology and cardiology, and for which the company holds regulatory safeguarded approvals.

View full analysis →

🔒 Detailed AI analysis, peer comparison, capital allocation, crisis resilience & PDF report for Pro members.

Not investment advice. Analyses are research, not a recommendation. Valuations may be erroneous or incomplete. © MoatScan.ai — proprietary methodology.